Insights into Asparaginase Allergic Responses: Exploring Pharmacogenetic Influences
Acute lymphoblastic leukemia represents the most prevalent childhood cancer. Modern chemotherapy has significantly improved outcomes, achieving EFS rates of 80% and OS rates nearing 90% in developed nations, while in developing regions, rates remain below 50%, highlighting disparities, and this diff...
Saved in:
Main Authors: | Daiane Keller Cecconello (Author), Klerize Anecely de Souza Silva (Author), Evelin Cristine Mendonça de Senna (Author), Ciliana Rechenmacher (Author), Liane Esteves Daudt (Author), Mariana Bohns Michalowski (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2024-08-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Epidemiological evaluation and survival of children with acute myeloid leukemia
by: Rahuany Velleda de Morais, et al.
Published: (2021) -
Activity of Erwinia-asparaginase after anaphylactic reaction to Peg-asparaginase
by: Maria Micaela Viña Romero, et al.
Published: (2019) -
Editorial: Insights in Pharmacogenetics and Pharmacogenomics: 2021
by: José A. G. Agúndez, et al.
Published: (2022) -
Insights into the Pharmacogenetics of Tacrolimus Pharmacokinetics and Pharmacodynamics
by: Mercè Brunet, et al.
Published: (2022) -
Peg-Grafted Liposomes for L-Asparaginase Encapsulation
by: Marina de Souza Guimarães, et al.
Published: (2022)